BindingDB logo
myBDB logout

14 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
26340601 54 Recent Update on Human Lactate Dehydrogenase Enzyme 5 (hLDH5) Inhibitors: A Promising Approach for Cancer Chemotherapy.EBI National Cancer Institute-CRO
26114812 26 Identification of N-acylhydrazone derivatives as novel lactate dehydrogenase A inhibitors.EBI University of Bologna
25288186 20 An update on therapeutic opportunities offered by cancer glycolytic metabolism.EBI Universit£ di Pisa
25466195 41 Optimization of 5-(2,6-dichlorophenyl)-3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase.EBI Genentech
25037916 185 Identification of substituted 3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase.EBI Genentech
25467161 43 Identification of 3,6-disubstituted dihydropyrones as inhibitors of human lactate dehydrogenase.EBI Genentech
24012183 91 Identification of 2-amino-5-aryl-pyrazines as inhibitors of human lactate dehydrogenase.EBI Genentech
23628333 69 Identification of substituted 2-thio-6-oxo-1,6-dihydropyrimidines as inhibitors of human lactate dehydrogenase.EBI Genentech
23302067 29 Fragment growing and linking lead to novel nanomolar lactate dehydrogenase inhibitors.EBI ARIAD Pharmaceuticals, Inc.
8308865 9 CNAD: a potent and specific inhibitor of alcohol dehydrogenase.EBI University of Rochester Medical Center
21332213 10 Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells.EBI Universita` di Pisa
9748363 30 Selective inhibitors of human lactate dehydrogenases and lactate dehydrogenase from the malarial parasite Plasmodium falciparum.EBI University of New Mexico School of Medicine
27479743 12 Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition.BDB Genentech
22417091 73 Design and synthesis of novel lactate dehydrogenase a inhibitors by fragment-based lead generation.BDB AstraZeneca